Abiopharma

Eaton Vance Limited Duration Income Fund, Eaton Vance Senior Floating-Rate Trust, and Eaton Vance Senior Income Trust Announce Final Results of Auction Preferred Shares Tender Offers

Amtech Systems Announces Proposed Public Offering of Common Stock

Curbline Properties Second Quarter 2026 Investment and Capital Markets Update

Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Central Securities Corporation Declares Dividend

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère

Forgent Power Solutions Announces Closing of Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)